Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today

The MGC Pharma share price is gaining today, up 3% in late morning trade. We take a look at what’s moving the shares.
The post Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today appeared first on The Motley Fool Australia. –

medical asx share price represented by doctor giving thumbs up

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is gaining today, up 2.5% in late morning trade.

MGC Pharmaceuticals (MGC Pharma) is a biopharma company that produces and develops phytocannabinoid-derived medicines. This morning, it announced an increase in the initial purchase order of one of its patented products.

At the time of writing, the MGC Pharmaceuticals share price has retreated slightly, trading at 8 cents, up 1.25%. 

Let’s take a closer look at the announcement and what it means for MGC Pharma shares. 

What did MGC Pharma report?

The MGC Pharma share price is gaining today. In particular, this comes after the company reported an 85% increase in the original purchase order for its medicinal food supplement ArtemiC Rescue from Swiss PharmaCan AG (SPC).

Additionally, shares zoomed 31% higher on 19 February following the initial announcement of the purchase order from SPC. SPC agreed to distribute ArtemiC Rescue worldwide for at least 3 years. The distribution will be focused on countries with high levels of COVID-19.

With the increased order, MGC Pharma reports the deal will result in at least $425,000 of wholesale revenue.

Management commentary

Commenting on the increased order, Roby Zomer, Managing Director of MGC Pharma said:

We are pleased to have extended our agreement with Swiss PharmaCan AG for ArtemiC Rescue. This further agreement will provide more people access to the natural therapeutic benefits of the supplement and ease suffering following the successful Phase II trial results in December.

ArtemiC Rescue is an anti-inflammatory product. It can be taken without any shown drug adverse side effects. Importantly, with direct applications in treating the coronavirus.

According to MGC Pharma, it’s been shown to reduce the severity of pain and other symptoms. Particularly, in patients infected with COVID-19. Additionally, it can be used in the community alongside hospital use. The company said it has the “ability to prevent deterioration of COVID-19 patients and achieve faster clinical improvement”.

Share price snapshot

Since this time last year, MGC Pharma shares have gained 173%. That compares to an 8% gain on the All Ordinaries Index (ASX: XAO).

Year-to-date the MGC Pharma share price is up 310%.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!